The new molecular biology of granulosa cell tumors of the ovary

Genome Medicine

Volumn 1, Issue 8, 2009, Pages

  Kalfa, Nicolas ^a   Veitia, Reiner A ^b,c   Benayoun, Bérénice A ^b,c   Boizet Bonhoure, Brigitte ^d   Sultan, Charles ^a,e  

^a LAPEYRONIE HOSPITAL   (France)

^b INSTITUT JACQUES MONOD   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d INSTITUTE OF HUMAN GENETICS   (France)

^e MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; MYC PROTEIN; PROTEIN KINASE LKB1; PROTEIN P21; PROTEIN P53; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXL2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ACUTE MYELOBLASTIC LEUKEMIA; BREAKTHROUGH BLEEDING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER SURGERY; CHILDHOOD CANCER; CLINICAL FEATURE; GENE EXPRESSION REGULATION; GENETIC MARKER; GRANULOSA CELL TUMOR; HUMAN; HYSTERECTOMY; LARYNX CANCER; MENORRHAGIA; METASTASIS; MISSENSE MUTATION; MOLECULAR BIOLOGY; ONCOGENE C ERB; OVARY TUMOR; PANCREAS CANCER; PATHOGENESIS; POSTMENOPAUSE; POSTOPERATIVE CARE; PREPUBERTY; PRIORITY JOURNAL; PROGNOSIS; PUBERTY; RHABDOMYOSARCOMA; SALPINGOOOPHORECTOMY; SHORT SURVEY;

EID: 77953369423     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm81     Document Type: Short Survey

References (42)

1. Schumer ST, Cannistra SA: Granulosa cell tumor of the ovary. J Clin Oncol 2003, 21:1180-1189.
2. Colombo N, Parma G, Zanagnolo V, Insinga A: Management of ovarian stromal cell tumors. J Clin Oncol 2007, 25:2944-2951.
3. Merras-Salmio L, Vettenranta K, Mottonen M, Heikinheimo M: Ovarian granulosa cell tumors in childhood. Pediatr Hematol Oncol 2002, 19:145-156.
4. Young RH, Dickersin GR, Scully RE: Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cases. Am J Surg Pathol 1984, 8:575-596.
5. Fuller PJ, Chu S, Fikret S, Burger HG: Molecular pathogene-sis of granulosa cell tumours. Mol Cell Endocrinol 2002, 191: 89-96.
6. Kalfa N, Patte C, Orbach D, Lecointre C, Pienkowski C, Philippe F, Thibault E, Plantaz D, Brauner R, Rubie H, Guedj AM, Ecochard A, Paris F, Jeandel C, Baldet P, Sultan C: A nationwide study of granulosa cell tumors in pre- and postpubertal girls: missed diagnosis of endocrine mani-festations worsens prognosis. J Pediatr Endocrinol Metab 2005, 18:25-31.
7. Evans AT, 3rd, Gaffey TA, Malkasian GD, Jr., Annegers JF: Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol 1980, 55:231-238.
8. Pectasides D, Papaxoinis G, Fountzilas G, Aravantinos G, Pectasides E, Mouratidou D, Economopoulos T, Andreadis C: Adult granulosa cell tumors of the ovary: a clinicopatho-logical study of 34 patients by the Hellenic Cooperative Oncology Group (HeCOG). Anticancer Res 2008, 28 (2B): 1421-1427.
9. Hasiakos D, Papakonstantinou K, Karvouni E, Fotiou S: Recurrence of granulosa cell tumor 25 years after initial diagnosis. Report of a case and review of the literature. Eur J Gynaecol Oncol 2008, 29:86-88.
10. Leuverink EM, Brennan BA, Crook ML, Doherty DA, Hammond IG, Ruba S, Stewart CJ: Prognostic value of mitotic counts and Ki-67 immunoreactivity in adult-type granulosa cell tumour of the ovary. J Clin Pathol 2008, 61:914-919.
11. Kalfa N, Sultan C: Juvenile ovarian granulosa cell tumor: a benign or malignant condition? Gynecol Endoc 2009, 25: 299.
12. Schmidt D, Ovitt CE, Anlag K, Fehsenfeld S, Gredsted L, Treier AC, Treier M: The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 2004, 131:933-942.
13. Uda M, Ottolenghi C, Crisponi L, Garcia JE, Deiana M, Kimber W, Forabosco A, Cao A, Schlessinger D, Pilia G: Foxl2 disrup-tion causes mouse ovarian failure by pervasive blockage of follicle development. Hum Mol Genet 2004, 13:1171-1181.
14. Cocquet J, Pailhoux E, Jaubert F, Servel N, Xia X, Pannetier M, De Baere E, Messiaen L, Cotinot C, Fellous M, Veitia RA: Evolution and expression of FOXL2. J Med Genet 2002, 39: 916-921.
15. Cocquet J, De Baere E, Gareil M, Pannetier M, Xia X, Fellous M, Veitia RA: Structure, evolution and expression of the FOXL2 transcription unit. Cytogenet Genome Res 2003, 101: 206-211.
16. Kalfa N, Philibert P, Patte C, Ecochard A, Duvillard P, Baldet P, Jaubert F, Fellous M, Sultan C: Extinction of FOXL2 expres-sion in aggressive ovarian granulosa cell tumors in chil-dren. Fertil Steril 2007, 87:896-901.
17. Shah SP, Köbel M, Senz J, Morin RD, Clarke BA, Wiegand KC, Leung G, Zayed A, Mehl E, Kalloger SE, Sun M, Giuliany R, Yorida E, Jones S, Varhol R, Swenerton KD, Miller D, Clement PB, Crane C, Madore J, Provencher D, Leung P, DeFazio A, Khattra J, Turashvili G, Zhao Y, Zeng T, Glover JN, Vanderhyden B, Zhao C, et al.: Mutation of FOXL2 in granu-losa-cell tumors of the ovary. N Engl J Med 2009, 360:2719-2729.
18. Wang ZJ, Churchman M, Campbell IG, Xu WH, Yan ZY, McCluggage WG, Foulkes WD, Tomlinson IP: Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours. Br J Cancer 1999, 80: 70-72.
19. Kato N, Romero M, Catasus L, Prat J: The STK11/LKB1 Peutz-Jegher gene is not involved in the pathogenesis of sporadic sex cord-stromal tumors, although loss of heter-ozygosity at 19p13.3 indicates other gene alteration in these tumors. Hum Pathol 2004, 35:1101-1104.
20. Kim K, Lindstrom MJ, Gould MN: Regions of H- and K-ras that provide organ specificity/potency in mammary cancer induction. Cancer Res 2002, 62:1241-1245.
21. King LA, Okagaki T, Gallup DG, Twiggs LB, Messing MJ, Carson LF: Mitotic count, nuclear atypia, and immunohisto-chemical determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: mitotic count and Ki-67 are indicators of poor prognosis. Gynecol Oncol 1996, 61:227-232.
22. Makrigiannakis A, Amin K, Coukos G, Tilly JL, Coutifaris C: Regulated expression and potential roles of p53 and Wilms' tumor suppressor gene (WT1) during follicular development in the human ovary. J Clin Endocrinol Metab 2000, 85:449-459.
23. Coppes MJ, Ye Y, Rackley R, Zhao XL, Liefers GJ, Casey G, Williams BR: Analysis of WT1 in granulosa cell and other sex cord-stromal tumors. Cancer Res 1993, 53:2712-2714.
24. Liu FS, Ho ES, Lai CR, Chen JT, Shih RT, Yang CH, Tsao CM: Overexpression of p53 is not a feature of ovarian granu-losa cell tumors. Gynecol Oncol 1996, 61:50-53.
25. Kappes S, Milde-Langosch K, Kressin P, Passlack B, Dockhorn-Dworniczak B, Rohlke P, Loning T: p53 mutations in ovarian tumors, detected by temperature-gradient gel elec-trophoresis, direct sequencing and immunohistochemis-try. Int J Cancer 1995, 64:52-59.
26. Chu S, Rushdi S, Zumpe ET, Mamers P, Healy DL, Jobling T, Burger HG, Fuller PJ: FSH-regulated gene expression pro-files in ovarian tumours and normal ovaries. Mol Hum Reprod 2002, 8:426-433.
27. Fuller PJ, Verity K, Shen Y, Mamers P, Jobling T, Burger HG: No evidence of a role for mutations or polymorphisms of the follicle-stimulating hormone receptor in ovarian granu-losa cell tumors. J Clin Endocrinol Metab 1998, 83:274-279.
28. Kotlar T, Young RH, Albanese C, Crowley WF Jr, Scully RE, Jameson JL: Absence of mutations in the FSH receptor in ovarian granulosa cell tumors. J Clin Endocrinol Metab 1998, 83:3001.
29. Bas F, Pescovitz OH, Steinmetz R: No activating mutations of FSH receptor in four children with ovarian juvenile gran-ulosa cell tumors and the association of these tumors with central precocious puberty. J Pediatr Adolesc Gynecol 2009, 22:173-179.
30. Fragoso MC, Latronico AC, Carvalho FM, Zerbini MC, Marcondes JA, Araujo LM, Lando VS, Frazzatto ET, Mendonca BB, Villares SM: Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors. J Clin Endocrinol Metab 1998, 83:2074-2078.
31. Ligtenberg MJ, Siers M, Themmen AP, Hanselaar TG, Willemsen W, Brunner HG: Analysis of mutations in genes of the follicle-stimulating hormone receptor signaling pathway in ovarian granulosa cell tumors. J Clin Endocrinol Metab 1999, 84:2233-2234.
32. Kalfa N, Ecochard A, Patte C, Duvillard P, Audran F, Pienkowski C, Thibaud E, Brauner R, Lecointre C, Plantaz D, Guedj AM, Paris F, Baldet P, Lumbroso S, Sultan C: Activating mutations of the stimulatory g protein in juvenile ovarian granulosa cell tumors: a new prognostic factor? J Clin Endocrinol Metab 2006, 91:1842-1847.
33. Chien J, Wong E, Nikes E, Noble MJ, Pantazis CG, Shah GV: Constitutive activation of stimulatory guanine nucleotide binding protein (G(S)alphaQL)-mediated signaling increases invasiveness and tumorigenicity of PC-3M pros-tate cancer cells. Oncogene 1999, 18:3376-3382.
34. Barr FG: Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Oncogene 2001, 20:5736-5746.
35. Hillion J, Le Coniat M, Jonveaux P, Berger R, Bernard OA: AF6q21, a novel partner of the MLL gene in t(6;11) (q21;q23), defines a forkhead transcriptional factor sub-family. Blood 1997, 90:3714-3719.
36. Mani H, Shilo K, Galvin JR, Stocker JT, Franks TJ: Spectrum of precursor and invasive neoplastic lesions in type 1 con-genital pulmonary airway malformation: case report and review of the literature. Histopathology 2007, 51:561-565.
37. Mani N, Lowe D, Pope L, El-Daly H, Pfleiderer A: An unusual case of laryngeal spindle cell carcinoma metastasising to the orbit and heart. J Laryngol Otol 2007, 121:e19.
38. Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, Miura N, Kutok JL, Hartwell K, Richardson AL, Weinberg RA: Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci USA 2007, 104:10069-10074.
39. Nakamura T, Furukawa Y, Nakagawa H, Tsunoda T, Ohigashi H, Murata K, Ishikawa O, Ohgaki K, Kashimura N, Miyamoto M, Hirano S, Kondo S, Katoh H, Nakamura Y, Katagiri T: Genome-wide cDNA microarray analysis of gene expres-sion profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 2004, 23:2385-2400.
40. Blount AL, Schmidt K, Justice NJ, Vale WW, Fischer WH, Bilezikjian LM: FoxL2 and Smad3 coordinately regulate fol-listatin gene transcription. J Biol Chem 2009, 284:7631-7645.
41. Ellsworth BS, Burns AT, Escudero KW, Duval DL, Nelson SE, Clay CM: The gonadotropin releasing hormone (GnRH) receptor activating sequence (GRAS) is a composite regu-latory element that interacts with multiple classes of tran-scription factors including Smads, AP-1 and a forkhead DNA binding protein. Mol Cell Endocrinol 2003, 206:93-111.
42. Dragovic RA, Ritter LJ, Schulz SJ, Amato F, Thompson JG, Armstrong DT, Gilchrist RB: Oocyte-secreted factor activa-tion of SMAD 2/3 signaling enables initiation of mouse cumulus cell expansion. Biol Reprod 2007, 76:848-857.